Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 8:54 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1585–1608 of 3,077 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Intracranial Vascular Disorders Clear all

Conditions: ESRD, Fabry Disease, Rare Diseases, Kidney Diseases, End Stage Renal Disease, Genetic Diseases, X-Linked
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 338 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Subarachnoid Hemorrhage, Acute Kidney Injury
Interventions: Sodium chloride /sodium acetate (16.4%), Sodium chloride (23.4%), PlasmaLyte; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Stroke, Stroke, Acute, Stroke, Ischemic
Interventions: Endovascular Stroke Treatment, Medical Management; Procedure · Other
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 1,060 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 35
States / cities: Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 27 more

Conditions: Stroke
Interventions: VR - Virtual Reality; Behavioral
Lead sponsor: University of Nebraska; Other
Eligibility: 21 Years and older
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Stroke, Gait Disorders, Neurologic
Interventions: REEV SENSE, Motion capture system; Device
Lead sponsor: REEV LLC; Industry
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Anxiety Depression, Aneurysm Cerebral, Mental Health Wellness 1
Interventions: Clipping, Endovascular embolization, Surveillance imaging; Procedure · Diagnostic Test
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Ischemic Stroke
Interventions: Q Therapeutic System (BQ 3.0) - Sham, Q Therapeutic System (BQ 3.0) - Active; Device
Lead sponsor: BrainQ Technologies Ltd.; Industry
Eligibility: 22 Years to 80 Years
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 14
States / cities: Downey, California • Washington D.C., District of Columbia • Jacksonville, Florida + 11 more

Conditions: Aneurysm Cerebral
Interventions: Observation; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Stroke, Brain Disease, Central Nervous System Diseases, Nervous System Diseases, Cardiovascular Diseases
Interventions: Deep Brain Stimulation (DBS) of the Motor Thalamus; Device
Lead sponsor: Jorge Gonzalez-Martinez; Other
Eligibility: 18 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Ischemic Stroke
Interventions: Trevo Thrombectomy Procedure, Medical Management; Device · Other
Lead sponsor: Stryker Neurovascular; Industry
Eligibility: 18 Years and older
Enrollment: 206 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 24
States / cities: Los Angeles, California • San Francisco, California • Newark, Delaware + 20 more

Conditions: Intracerebral Hemorrhage
Interventions: Recombinant Factor VIIa, Biological/Vaccine: Placebo; Biological
Lead sponsor: Joseph Broderick, MD; Other
Eligibility: 18 Years to 80 Years
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 49
States / cities: Birmingham, Alabama • Baldwin Park, California • Burlingame, California + 39 more

Conditions: Acute Ischemic Stroke
Interventions: Mechanical Thrombectomy; Procedure
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 2
States / cities: Iowa City, Iowa • Cleveland, Ohio

Conditions: Subarachnoid Hemorrhage, Ruptured Intracranial Aneurysm
Interventions: NA-1, Placebo; Drug
Lead sponsor: NoNO Inc.; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 5
States / cities: Phoenix, Arizona • Englewood, Colorado • Ann Arbor, Michigan + 2 more

Conditions: Hypercholesterolemia, Carotid Intimal Medial Thickness 1, Seizure, Epilepsy, Cardiovascular Disease, Cerebrovascular Disease, Heart Disease, Coronary Disease
Interventions: Modified Atkins or Ketogenic Diet; Dietary Supplement
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 105 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Neonatal Seizure, Hypoxic-Ischemic Encephalopathy, Stroke, Intracranial Hemorrhage, Epilepsy, Gene Abnormality
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: Not listed
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 8
States / cities: San Francisco, California • Washington D.C., District of Columbia • Boston, Massachusetts + 4 more

Conditions: Carotid Atherosclerosis, Carotid Artery Stenosis Asymptomatic, Asymptomatic Carotid Artery Stenosis
Interventions: 64Cu-NODAGA-CANF; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Los Angeles, California • St Louis, Missouri

Conditions: Stroke
Interventions: Dexedrine, Active tDCS, Speech Therapy, Placebo, Sham tDCS; Drug · Device · Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Vasculitis, Wegener's Granulomatosis, Microscopic Polyangiitis
Interventions: Rituximab plus cyclophosphamide placebo (rituximab group), Cyclophosphamide plus rituximab placebo (control group), Azathioprine, Methylprednisolone (or other glucocorticoid), Prednisone; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 15 Years and older
Enrollment: 197 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 7
States / cities: Birmingham, Alabama • Baltimore, Maryland • Boston, Massachusetts + 4 more

Conditions: Thromboembolic Events
Interventions: Not listed
Lead sponsor: Texas Cardiac Arrhythmia Research Foundation; Other
Eligibility: Not listed
Enrollment: 40 participants
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Urinary Incontinence, Bladder Dysfunction
Interventions: Fesoterodine Oral Product; Drug
Lead sponsor: Saint Thomas Health; Other
Eligibility: 21 Years to 85 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Intracranial Aneurysm, Aneurysm, Intracranial, Giant Intracranial Aneurysm
Interventions: TCD Ultrasound; Device
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Cerebrovascular Stroke
Interventions: Transcranial Magnetic Stimulation, Traditional Paired Associative Stimulation, Median Nerve Stimulation, Corticocortical Paired Associative Stimulation, Sham Paired Associative Stimulation; Device
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Stroke, Sensorimotor Impairment
Interventions: Visuomotor learning task; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Stroke, Ischemic, Pain, Postoperative, Substance Abuse, Subarachnoid Hemorrhage
Interventions: Placebo, NP10679; Drug
Lead sponsor: Neurop Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Baltimore, Maryland

Search by objective public record fields.

Kidney Information Network for Disease Research and Education

A Low ChloridE hyperTonic Solution for Brain Edema

Treatment With Endovascular Intervention for STroke Patients With Existing Disability

Virtual Reality Augmented Gait Adaptation in Stroke Survivors

REEV SENSE for Gait Analysis in Post-stroke Gait Impairment (SENS-AG)

Psychiatric Outcomes of Unruptured Intracranial Aneurysms (POUIA)

EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment

Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy

Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke

Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention With Trevo

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

Mild Acute Ischemic Stroke With Large Vessel Occlusion (MISTWAVE)

Safety and Efficacy Study of a Single Dose of NA-1 in Patients Undergoing Endovascular Repair of Ruptured Aneurysms

Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy

Neonatal Seizure Registry, GEnetics of Post-Neonatal Epilepsy

PET-MR Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With 64Cu-NODAGA-CANF (Multisite)

Dextroamphetamine and tDCS to Improve the Fluency

Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis

Association of Genetic Variants With Risk of Stroke in Patients With Atrial Fibrillation Off-anticoagulation

Neuropathic Investigation and Anticholinergic Treatment of Bladder Dysfunction in Diabetes and Stroke Patients

Transcranial Doppler Ultrasound Monitoring During Flow-Diverter Embolization

Noninvasive Brain Stimulation to Evaluate Neural Plasticity After Stroke

Learning in Stroke

A Multiple Ascending Dose Study of Safety and Pharmacokinetics of NP10679 in Normal Healthy Volunteers